Imodium multi-symptom relief and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium multi-symptom relief (loperamide hydrochloride; simethicone) and Reglan (metoclopramide hydrochloride). Common drug interactions include syncope among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium multi-symptom relief and Reglan. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium multi-symptom relief?

Imodium multi-symptom relief has active ingredients of loperamide hydrochloride; simethicone. It is often used in diarrhea. eHealthMe is studying from 5,486 Imodium multi-symptom relief users. Check the latest studies of Imodium multi-symptom relief.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

14 people who take Imodium multi-symptom relief and Reglan together, and have interactions are studied.

Imodium multi-symptom relief and Reglan drug interactions.

What are the common drug interactions of Imodium Multi-Symptom Relief and Reglan, by gender? *:

female:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Cholecystitis acute (rapid infection of gallbladder)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Death
  7. Pneumonia

male:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Decreased interest
  4. Dehydration (dryness resulting from the removal of water)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Duodenitis (inflammation of the duodenum)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  9. Extrasystoles
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Imodium Multi-Symptom Relief and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Cholecystitis acute (rapid infection of gallbladder)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Localised infection (infection at the single location)
  2. Cardiac failure congestive
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Hyperglycaemia (high blood sugar)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Cataract (clouding of the lens inside the eye)
  7. Abdominal discomfort
  8. Abdominal distension
  9. Anaemia (lack of blood)
  10. Anxiety

50-59:

  1. Death

60+:

  1. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  2. Large intestine perforation (hole in large intestine)
  3. Oral pain
  4. Pneumonia
  5. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Restless legs syndrome (a powerful urge to move your legs)
  8. Small intestinal obstruction (blockage in small intestine)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Tardive dyskinesia (a disorder that involves involuntary movements)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 3 people, 21.43%
  2. Nausea And Vomiting: 3 people, 21.43%
  3. Nausea (feeling of having an urge to vomit): 3 people, 21.43%
  4. Depression: 3 people, 21.43%
  5. Premenstrual Syndrome: 2 people, 14.29%
  6. Ovarian Cysts (fluid filled sacs of the ovary): 2 people, 14.29%
  7. Abdominal Pain: 2 people, 14.29%
  8. Muscle Aches (muscle pain): 1 person, 7.14%
  9. Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
  10. Malignant Ascites (a condition in which a person with cancer has an accumulation of fluid in the abdomen): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium multi-symptom relief and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium multi-symptom relief and Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium multi-symptom relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium multi-symptom relief and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride; simethicone and metoclopramide hydrochloride (the active ingredients of Imodium multi-symptom relief and Reglan, respectively), and Imodium multi-symptom relief and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: